Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ACAD > SEC Filings for ACAD > Form 8-K on 11-Mar-2014All Recent SEC Filings

Show all filings for ACADIA PHARMACEUTICALS INC

Form 8-K for ACADIA PHARMACEUTICALS INC


11-Mar-2014

Change in Directors or Principal Officers, Financial Statements and Ex


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) On March 7, 2014, the Board of Directors of ACADIA Pharmaceuticals Inc. (the "Company") adopted an updated annual incentive cash compensation program for its executive officers to be effective beginning with 2014. The description of this program is set forth in Exhibit 99.1 and is incorporated herein by reference.

On March 7, 2014, in connection with the previously announced planned retirement of Mr. Thomas Aasen, the Company's Executive Vice President, Chief Financial Officer and Chief Business Officer, the Company's Board of Directors approved modifications to Mr. Aasen's outstanding option grants in recognition of his over 15 years of service to the Company. Effective immediately prior to the date of Mr. Aasen's retirement, the vesting of each outstanding option that is not already fully vested will be accelerated by six months and the exercise period of each outstanding option shall continue until the earlier of (i) 18 months from such retirement date and (ii) the original term of such option.



Item 9.01 Financial Statements and Exhibits.

(d) 99.1 Description of Executive Officer Annual Incentive Cash Compensation Program


  Add ACAD to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ACAD - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.